Apremilast Tablets 10mg Technical Specification:
| Product Name: | Apremilast Tablets 10mg |
| Brand Name: | Generics |
| Strength: | (10mg), (20mg), (30mg) |
| Dosage Form: | Tablets (Film-coated) |
| Route of Administration: | Via oral Route |
| Packing: | 10s, 30s, 100s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP, CTD Dossier |
| Therapeutic use: | Anti-Ulcer |
| Indication: | Apremilast is used to treat ulcers in the mouth in people with Behcet’s syndrome (a disorder that causes blood vessel swelling in the body). Apremilast is in a class of medications called phosphodiesterase inhibitors. It works by blocking the action of certain natural substances in the body that cause inflammation. |
| Storage: | Store at 20˚ to 25˚C (68˚ to 77˚F). See USP Controlled Room Temperature. Protect from Light and moisture. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Apremilast Tablets 10mg
- Apremilast Tablets 20mg
- Apremilast Tablets 30mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Apremilast Tablets 10mg
Each Film-coated tablet contains:
Apremilast USP………………10mg
Excipients…………………q.s.
Colours: Ferric Oxide Red USP NF
- Apremilast Tablets 20mg
Each Film-coated tablet contains:
Apremilast USP………………20mg
Excipients…………………………q.s.
Colours: Ferric Oxide Yellow USP NF
- Apremilast Tablets 30mg
Each Film-coated tablet contains:
Apremilast USP………………30mg
Excipients…………………………q.s.
Colours: Ferrosoferric oxide USP-NF
THERAPEUTIC INDICATIONS:
Apremilast is used to treat ulcers in the mouth in people with Behcet’s syndrome (a disorder that causes blood vessel swelling in the body). Apremilast is in a class of medications called phosphodiesterase inhibitors. It works by blocking the action of certain natural substances in the body that cause inflammation.
CAUTION & WARNING:
CAUTION:
Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Storage: Store at 20˚ to 25˚C (68˚ to 77˚F). See USP Controlled Room Temperature. Protect from Light and moisture.
Dosage: As directed by the Physician.
GENERIC NAME OF THE MEDICINAL PRODUCT:
B. Apremilast Tablets 20mg
C. Apremilast Tablets 30mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each Film-coated tablet contains:
Apremilast USP………………10mg
Excipients…………………q.s.
Colours: Ferric Oxide Red USP NF
b) Apremilast Tablets 20mg
Each Film-coated tablet contains:
Apremilast USP………………20mg
Excipients…………………………q.s.
Colours: Ferric Oxide Yellow USP NF
c) Apremilast Tablets 30mg
Each Film-coated tablet contains:
Apremilast USP………………30mg
Excipients…………………………q.s.
Colours: Ferrosoferric oxide USP-NF
THERAPEUTIC INDICATIONS:
CAUTION & WARNING:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Dosage: As directed by the Physician.

